Literature DB >> 15603836

Bacillus cereus infections in Traumatology-Orthopaedics Department: retrospective investigation and improvement of healthcare practices.

A Dubouix1, E Bonnet, M Alvarez, H Bensafi, M Archambaud, B Chaminade, G Chabanon, N Marty.   

Abstract

OBJECTIVE: To investigate 41 open fractures infected with Bacillus cereus in a Traumatology-Orthopaedy ward and propose a care protocol at admission.
METHODS: All B. cereus strains isolated from patients hospitalized in the Traumatology-Orthopaedy ward between March 1997 and August 2001 were submitted to molecular analysis (RAPD and PFGE) in order to investigate a putative outbreak. Susceptibility to the main antibiotics and antiseptics used in this kind of surgery was also evaluated.
RESULTS: The B. cereus clinical isolates were mainly isolated from patients who had initially open fractures and were not clonally related. Furthermore, analysis of the clinical data was in favour of a telluric contamination of the wound (wound contamination with terrestrial environments) before admission. Finally, betalactam antibiotics used for prophylactic chemotherapy were not effective against the strains tested as well as the antiseptics who displayed poor effect.
CONCLUSION: B. cereus could be termed an emerging pathogen and people need to be aware of its potential importance in orthopaedic trauma cases. In this purpose, a systematic screening for B. cereus at admission should be necessary in front of patients with open fractures associated with telluric contamination. Furthermore, if this bacterium can be isolated, chemotherapy should be based upon ciprofloxacin that would prevent the development of B. cereus infection responsible for deleterious complications.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15603836     DOI: 10.1016/j.jinf.2004.05.012

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  8 in total

1.  The dangers of sublethal carvacrol exposure: increases in virulence of Bacillus cereus during endophthalmitis.

Authors:  Niloofar Rajabli; Lauren Williamson; Pierre S Nimmer; Marie Kelly-Worden; Jill S Bange; Yenling Ho; John L McKillip
Journal:  Int J Biochem Mol Biol       Date:  2018-10-08

2.  A single institutional review of pediatric Bacillus spp. bloodstream infections demonstrates increased incidence among children with cancer.

Authors:  David S Shulman; Preeti Mehrotra; Traci M Blonquist; Andrew Capraro; Leslie E Lehmann; Lewis B Silverman; Neeraj K Surana; Andrew E Place
Journal:  Pediatr Blood Cancer       Date:  2018-12-11       Impact factor: 3.167

3.  In vitro activities of daptomycin, ciprofloxacin, and other antimicrobial agents against the cells and spores of clinical isolates of Bacillus species.

Authors:  Diane M Citron; Maria D Appleman
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

Review 4.  Bacillus cereus, a volatile human pathogen.

Authors:  Edward J Bottone
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 5.  Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature.

Authors:  Romain Lotte; Alicia Chevalier; Laurent Boyer; Raymond Ruimy
Journal:  Clin Microbiol Rev       Date:  2022-02-09       Impact factor: 50.129

6.  Cutaneous infection due to Bacillus cereus: a case report.

Authors:  Mohammad Esmkhani; Saeed Shams
Journal:  BMC Infect Dis       Date:  2022-04-21       Impact factor: 3.667

7.  Bacillus cereus bacteraemia: comparison between haematologic and nonhaematologic patients.

Authors:  S Tusgul; G Prod'hom; L Senn; R Meuli; P-Y Bochud; S G Giulieri
Journal:  New Microbes New Infect       Date:  2016-11-17

8.  Post-procedural Bacillus cereus septic arthritis in a patient with systemic lupus erythematosus.

Authors:  Barend Mitton; Roxanne Rule; Nontombi Mbelle; Wesley van Hougenhouck-Tulleken; Mohamed Said
Journal:  Afr J Lab Med       Date:  2020-08-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.